'Mad Money Lightning Round': Stick With JPMorgan
Cramer says it's the best-run and best-capitalized company.
07:20PM 12/02/09
Cramer's 'Mad Money' Recap: Amazon's Amazing Run (Final)
Cramer says the stock of the Internet retail giant could top $216 next year.
06:34PM 12/02/09
Boise Shareholders Sell $78.6M in Secondary Offering
Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.
09:38AM 11/24/09
Cel-Sci's History of Disappearing Drugs: BioBuzz
Will Cel-Sci's flu drug last longer than its other fly-by-night projects?
09:20AM 11/24/09
BioCryst Bull Blames Conspiracy for Stock's Fall: BioBuzz
Hedge funds, Wall Street, SEC and FDA out to hurt maker of flu drug, newsletter writer claims.
06:45AM 11/24/09
U.S. Sees Low Demand for BioCryst Flu Drug
Peaking flu season could mean no need for further peramivir orders.
11:12AM 11/18/09
So far, it is just some mild consolidation after a big day yesterday.
10:29AM 11/17/09
Keep an Eye on the Dollar (Top Stocks $)
A number of technical developments in the greenback warrant some scrutiny.
07:29PM 11/16/09
Dangerous Action (RealMoney.com $)
Outperformance by big-cap tech is hiding some decidedly mixed action below the surface.
03:04PM 11/10/09
Oculus, Bianco and Cel-Sci Oh My!: BioBuzz
Some Friday Fall tidbits from the biotech stock world.
10:53AM 11/06/09
BioCryst Competition for IV Flu Drug: BioBuzz
U.S. government orders IV versions of two flu drugs to treat hospitalized patients.
06:29AM 11/06/09
BioCryst Winners and Losers: BioBuzz
Sorting out the latest salvo in the H1N1 investor war
02:32PM 11/05/09
'Fast Money' Portfolios of the Week
Here's what the 'Fast Money' crew's been talking about lately.
12:46PM 11/05/09
Cel-Sci's Lawyer Speaks: BioBuzz
Cel-Sci's complaint avoids the central issue about its mystery South African partner.
10:40AM 11/05/09



Connect with TheStreet